Sunflower Pharmaceutical Group Co.,Ltd (002737.SZ)

CNY 20.79

(0.43%)

Market Cap (In CNY)

12.14 Billion

Revenue (In CNY)

5.63 Billion

Net Income (In CNY)

1.11 Billion

Avg. Volume

4.64 Million

Currency
CNY
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
18.22-30.79
PE
-
EPS
-
Beta Value
0.349
ISIN
CNE100001WT7
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Ms. Yi Guan
Employee Count
-
Website
https://www.kuihuayaoye.com
Ipo Date
2014-12-30
Details
Sunflower Pharmaceutical Group Co.,Ltd researches, develops, manufactures, and markets Chinese patent medicines in China. The company also produces chemical, biological, and health care medicines. Its products are used in therapeutic areas, such as pediatrics, gynecology, digestive system, respiratory and cold, rheumatism and bone disease, and cardiovascular and cerebrovascular. The company sells its products under the Sunflower and Little Sunflower brands. Sunflower Pharmaceutical Group Co.,Ltd was founded in 2005 and is based in Harbin, China.